Market Tracker

04/20 5:15pm ET

OPKO Health Inc (NASDAQ:OPK)

3.08
Delayed Data
As of 4:00pm ET
 -0.09 / -2.84%
Today’s Change
2.66
Today|||52-Week Range
7.90
-37.14%
Year-to-Date
Weekly CEO Buys Highlight
Apr 16 / GuruFocus News - Paid Partner Content
Top Insider Buys Highlight for the Week of April 13
Apr 14 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close3.17
Today’s open3.18
Day’s range3.08 - 3.19
Volume2,608,579
Average volume (3 months)4,608,800
Market cap$2.0B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-1,000.00%
Earnings growth (this year)-71.88%
Earnings growth (next 5 years)+52.05%
Revenue growth (last year)-12.62%
P/E ratioNM
Price/Sales2.57
Price/Book1.07

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.27+0.82%
PBYIPuma Biotechnology I...-1.10-1.76%
CLVSClovis Oncology Inc-1.15-2.24%
MNKMallinckrodt Plc-0.28-1.99%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1B
Annual profit (last year)-$308.9M
Net profit margin-28.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts